Aldeyra Therapeutics, Inc. - Common Stock — 재무제표 (NASDAQ:ALDX) | MetaTrader

전체 차트 열기 Full chart

Financials

개요 성명 통계

총자산 83.35 M233.14 M181.29 M148.33 M104.61 M72.06 M 총 부채 23.84 M27.4 M30.28 M28.53 M33.6 M27.81 M 자본금 총액 59.51 M205.74 M151.01 M119.8 M71 M44.25 M 총 부채 및 주주자본 83.35 M233.14 M181.29 M148.33 M104.61 M72.06 M 총부채 11.43 M15.5 M14.92 M015 M15.25 M 순부채 11.43 M15.5 M14.92 M015 M-70.04 M

뉴스

Shareholders Sue Aldeyra Therapeutics Over Dry Eye Drug Claims - TipRanks.com

AbbVie: Buy Or Sell Ahead Of Q1 Earnings? It's A Buy, But With Caveats (Upgrade) (ABBV)

ALDX Crashes 71% as FDA Issues Third CRL for Dry Eye Disease Drug NDA

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.10%

바슈롬, 경쟁사 이디 치료제 지연에 RBC ’아웃퍼폼’ 유지

RBC reiterates Bausch & Lomb stock rating on DED rival delay

FDA rejects Aldeyra’s dry eye disease drug application

Is Aldeyra Therapeutics (ALDX) Outperforming Other Medical Stocks This Year?

Does Aldeyra Therapeutics (ALDX) Have the Potential to Rally 79.28% as Wall Street Analysts Expect?

BTIG 선정, 2026년 최고 헬스케어 주식

Top Healthcare Stocks for This Year According to BTIG

Wall Street Analysts Predict a 65.75% Upside in Aldeyra Therapeutics (ALDX): Here's What You Should Know